Cargando…

Drug use and antiretroviral therapy (ART) interactions: a qualitative study to explore the knowledge, beliefs, adherence, and quality of life of people living with HIV taking ART and illicit drugs

BACKGROUND: To explore the use of illicit drugs by people living with HIV (PLHIV) taking antiretroviral therapy (ART) and their relationship with variables relevant to the management of HIV infection, such as knowledge and beliefs about drug–drug interactions (DDIs), ART adherence, quality of life (...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuster-RuizdeApodaca, María José, Castro-Granell, Vanessa, Laguía, Ana, Jaén, Ángeles, Cenoz, Santiago, Galindo, María José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245822/
https://www.ncbi.nlm.nih.gov/pubmed/32448214
http://dx.doi.org/10.1186/s12981-020-00279-y
_version_ 1783537824999407616
author Fuster-RuizdeApodaca, María José
Castro-Granell, Vanessa
Laguía, Ana
Jaén, Ángeles
Cenoz, Santiago
Galindo, María José
author_facet Fuster-RuizdeApodaca, María José
Castro-Granell, Vanessa
Laguía, Ana
Jaén, Ángeles
Cenoz, Santiago
Galindo, María José
author_sort Fuster-RuizdeApodaca, María José
collection PubMed
description BACKGROUND: To explore the use of illicit drugs by people living with HIV (PLHIV) taking antiretroviral therapy (ART) and their relationship with variables relevant to the management of HIV infection, such as knowledge and beliefs about drug–drug interactions (DDIs), ART adherence, quality of life (QoL), and use of health-care resources. METHODS: 21 PLHIV in Spain who concomitantly took illicit drugs and ART participated in this qualitative study. Eight experts collaborated in the design of the semi-structured interview guide which explored the following topics: illicit drug use, knowledge and beliefs about DDIs and their impact on ART adherence, the effects of using illicit drugs on health, QoL, and use of health-care resources. Four of those experts, who were PLHIV and members of the executive boards of non-government organizations (NGOs) from four Spanish regions, recruited the participants through their NGOs and carried out the face-to-face interviews. Content analysis of the qualitative data was conducted with the support of the MAXQDA 12 program. RESULTS: Participants were mainly men (85.7%) and only 14.3% of them were heterosexual. Content analysis showed that the most frequently consumed illicit drugs were poppers, cocaine, and cannabis. Participants were polydrug users and this was, in many cases, prior to HIV diagnosis. Most participants presented theoretical potential moderate DDIs that would require monitoring. More than three quarters of them were not aware of these DDIs. Participants reported interactive toxicity beliefs that lead to intentional nonadherence behaviors. In most cases (n = 17), the participant’s doctor knew about their drug use, however only six of them had had an open dialogue with their physician about it. Illicit drug use led to some health-related problems, mainly sexually transmitted infections. A positive QoL’s self-perception was found among several participants that used recreational illicit drugs. CONCLUSIONS: Adequate information about DDIs and clues about how to manage ART when PLHIV are using illicit drugs could reduce the negative effects of such interactions and improve ART adherence and QoL.
format Online
Article
Text
id pubmed-7245822
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72458222020-06-01 Drug use and antiretroviral therapy (ART) interactions: a qualitative study to explore the knowledge, beliefs, adherence, and quality of life of people living with HIV taking ART and illicit drugs Fuster-RuizdeApodaca, María José Castro-Granell, Vanessa Laguía, Ana Jaén, Ángeles Cenoz, Santiago Galindo, María José AIDS Res Ther Research BACKGROUND: To explore the use of illicit drugs by people living with HIV (PLHIV) taking antiretroviral therapy (ART) and their relationship with variables relevant to the management of HIV infection, such as knowledge and beliefs about drug–drug interactions (DDIs), ART adherence, quality of life (QoL), and use of health-care resources. METHODS: 21 PLHIV in Spain who concomitantly took illicit drugs and ART participated in this qualitative study. Eight experts collaborated in the design of the semi-structured interview guide which explored the following topics: illicit drug use, knowledge and beliefs about DDIs and their impact on ART adherence, the effects of using illicit drugs on health, QoL, and use of health-care resources. Four of those experts, who were PLHIV and members of the executive boards of non-government organizations (NGOs) from four Spanish regions, recruited the participants through their NGOs and carried out the face-to-face interviews. Content analysis of the qualitative data was conducted with the support of the MAXQDA 12 program. RESULTS: Participants were mainly men (85.7%) and only 14.3% of them were heterosexual. Content analysis showed that the most frequently consumed illicit drugs were poppers, cocaine, and cannabis. Participants were polydrug users and this was, in many cases, prior to HIV diagnosis. Most participants presented theoretical potential moderate DDIs that would require monitoring. More than three quarters of them were not aware of these DDIs. Participants reported interactive toxicity beliefs that lead to intentional nonadherence behaviors. In most cases (n = 17), the participant’s doctor knew about their drug use, however only six of them had had an open dialogue with their physician about it. Illicit drug use led to some health-related problems, mainly sexually transmitted infections. A positive QoL’s self-perception was found among several participants that used recreational illicit drugs. CONCLUSIONS: Adequate information about DDIs and clues about how to manage ART when PLHIV are using illicit drugs could reduce the negative effects of such interactions and improve ART adherence and QoL. BioMed Central 2020-05-24 /pmc/articles/PMC7245822/ /pubmed/32448214 http://dx.doi.org/10.1186/s12981-020-00279-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Fuster-RuizdeApodaca, María José
Castro-Granell, Vanessa
Laguía, Ana
Jaén, Ángeles
Cenoz, Santiago
Galindo, María José
Drug use and antiretroviral therapy (ART) interactions: a qualitative study to explore the knowledge, beliefs, adherence, and quality of life of people living with HIV taking ART and illicit drugs
title Drug use and antiretroviral therapy (ART) interactions: a qualitative study to explore the knowledge, beliefs, adherence, and quality of life of people living with HIV taking ART and illicit drugs
title_full Drug use and antiretroviral therapy (ART) interactions: a qualitative study to explore the knowledge, beliefs, adherence, and quality of life of people living with HIV taking ART and illicit drugs
title_fullStr Drug use and antiretroviral therapy (ART) interactions: a qualitative study to explore the knowledge, beliefs, adherence, and quality of life of people living with HIV taking ART and illicit drugs
title_full_unstemmed Drug use and antiretroviral therapy (ART) interactions: a qualitative study to explore the knowledge, beliefs, adherence, and quality of life of people living with HIV taking ART and illicit drugs
title_short Drug use and antiretroviral therapy (ART) interactions: a qualitative study to explore the knowledge, beliefs, adherence, and quality of life of people living with HIV taking ART and illicit drugs
title_sort drug use and antiretroviral therapy (art) interactions: a qualitative study to explore the knowledge, beliefs, adherence, and quality of life of people living with hiv taking art and illicit drugs
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245822/
https://www.ncbi.nlm.nih.gov/pubmed/32448214
http://dx.doi.org/10.1186/s12981-020-00279-y
work_keys_str_mv AT fusterruizdeapodacamariajose druguseandantiretroviraltherapyartinteractionsaqualitativestudytoexploretheknowledgebeliefsadherenceandqualityoflifeofpeoplelivingwithhivtakingartandillicitdrugs
AT castrogranellvanessa druguseandantiretroviraltherapyartinteractionsaqualitativestudytoexploretheknowledgebeliefsadherenceandqualityoflifeofpeoplelivingwithhivtakingartandillicitdrugs
AT laguiaana druguseandantiretroviraltherapyartinteractionsaqualitativestudytoexploretheknowledgebeliefsadherenceandqualityoflifeofpeoplelivingwithhivtakingartandillicitdrugs
AT jaenangeles druguseandantiretroviraltherapyartinteractionsaqualitativestudytoexploretheknowledgebeliefsadherenceandqualityoflifeofpeoplelivingwithhivtakingartandillicitdrugs
AT cenozsantiago druguseandantiretroviraltherapyartinteractionsaqualitativestudytoexploretheknowledgebeliefsadherenceandqualityoflifeofpeoplelivingwithhivtakingartandillicitdrugs
AT galindomariajose druguseandantiretroviraltherapyartinteractionsaqualitativestudytoexploretheknowledgebeliefsadherenceandqualityoflifeofpeoplelivingwithhivtakingartandillicitdrugs